These include the cell death receptor FAS, MGMT (that provides TMZ resistance in GBM through promoter methylation), FGFR2, glutamine metabolism genes such as GOT1 and GLUD1, the multidrug resistance transporter ABCC2, and the glycolytic enzyme PGAM1 among many others. This evidence concerns the gene GLUD1 and glioblastoma.